AI AI-Powered Drug Development Startup Pathos AI Closes $365M InvestmentMay 23, 2025 Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, has raised $365 million in a late-stage funding round, bringing its valuation to $1.6 billion.